Manmeet S. Soni

2021 - REATA PHARMACEUTICALS

In 2021, Manmeet S. Soni earned a total compensation of $3M as Chief Operation Officer, Chief Financial Officer and President at REATA PHARMACEUTICALS, a 33% decrease compared to previous year.

Compensation breakdown

Bonus$204,752
Option Awards$1,823,878
Salary$545,900
Other$401,214
Total$2,975,743

Soni received $1.8M in option awards, accounting for 61% of the total pay in 2021.

Soni also received $204.8K in bonus, $545.9K in salary and $401.2K in other compensation.

Rankings

In 2021, Manmeet S. Soni's compensation ranked 4,465th out of 12,415 executives tracked by ExecPay. In other words, Soni earned more than 64.0% of executives.

ClassificationRankingPercentile
All
4,465
out of 12,415
64th
Division
Manufacturing
1,838
out of 5,505
67th
Major group
Chemicals And Allied Products
766
out of 2,375
68th
Industry group
Drugs
683
out of 2,096
67th
Industry
Pharmaceutical Preparations
488
out of 1,546
68th

Pay ratio

Manmeet S. Soni's Pay$2,975,743
Median Employee's Pay$244,581
Pay Ratio

12

to 1

In 2021, the annual total compensation of Manmeet S. Soni was $2,975,743.

The annual total compensation of the median employee at REATA PHARMACEUTICALS was $244,581.

The ratio of Manmeet S. Soni's pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on April 29, 2022.

Soni's colleagues

We found four more compensation records of executives who worked with Manmeet S. Soni at REATA PHARMACEUTICALS in 2021.

2021

J Huff

REATA PHARMACEUTICALS

Chief Executive Officer

2021

Colin Meyer

REATA PHARMACEUTICALS

Chief Innovation Officer and Executive Vice President

2021

Dawn Bir

REATA PHARMACEUTICALS

Chief Commercial Officer and Executive Vice President

2021

Michael Wortley

REATA PHARMACEUTICALS

Chief Legal Officer

News

In-depth

You may also like